|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,400.00 JPY | +7.78% |
|
+19.07% | -10.45% |
| 02-20 | Japan Panel Clears First iPS Cell Therapies for Conditional Sale | MT |
| 02-19 | Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's | RE |
| Market Cap | 44.6B 280M 243M 227M 207M 390M 26.71B 397M 2.66B 1.04B 13.37B 1.05B 1.03B | P/E 2025 |
-103x | P/E 2026 | -56.3x |
|---|---|---|---|---|---|
| Enterprise Value | 40.7B 256M 221M 207M 189M 356M 24.37B 362M 2.43B 952M 12.2B 959M 939M | EV / Sales 2025 |
356x | EV / Sales 2026 | 255x |
| Free-Float |
74.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +7.78% | ||
| 1 week | +19.07% | ||
| Current month | +20.40% | ||
| 1 month | +12.38% | ||
| 3 months | -14.96% | ||
| 6 months | -37.28% | ||
| Current year | -10.45% |
| 1 week | 4,670 |  | 5,490 |
| 1 month | 4,090 | | 5,490 |
| Current year | 3,610 | | 12,400 |
| 1 year | 3,610 | | 12,400 |
| 3 years | 1,443 | | 12,400 |
| 5 years | 1,287 | | 12,400 |
| 10 years | 1,287 | | 12,400 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/06/2020 | |
Yoshiki Sawa
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/08/2021 |
| Investor Relations Contact | 44 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 01/08/2020 | |
Yoshiki Sawa
BRD | Director/Board Member | 71 | 01/08/2021 |
Tadashi Samejima
BRD | Director/Board Member | 66 | 01/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/02/25 | Others | Chief Technology Officer | 24,000 | 0.2989% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.78% | +19.07% | -10.74% | +216.90% | 281M | |
| -1.37% | +4.78% | +45.99% | -1.23% | 80.69B | |
| +2.55% | +13.07% | +2.40% | +30.48% | 51.22B | |
| +0.49% | +2.17% | +22.60% | +177.89% | 49.58B | |
| +2.87% | +11.29% | -46.98% | -47.72% | 45.5B | |
| -1.56% | -2.19% | +59.29% | -25.50% | 30.6B | |
| -0.39% | +0.39% | +52.89% | +83.63% | 24.64B | |
| +1.27% | +6.28% | +137.81% | -40.32% | 23.88B | |
| -1.80% | +11.10% | +4.71% | +196.74% | 21.59B | |
| -5.89% | +34.09% | -0.99% | +792.56% | 17.09B | |
| Average | +0.39% | +663.44% | +26.70% | +138.34% | 34.51B | |
| Weighted average by Cap. | +0.03% | +274.63% | +26.97% | +76.16% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 175M 1.1M 952K 891K 813K 1.53M 105M 1.56M 10.45M 4.1M 52.46M 4.13M 4.04M | 212M 1.33M 1.15M 1.08M 985K 1.85M 127M 1.89M 12.66M 4.96M 63.55M 5M 4.89M |
| Net income | -644M -4.04M -3.5M -3.28M -2.99M -5.63M -386M -5.73M -38.46M -15.07M -193M -15.18M -14.85M | -1.02B -6.42M -5.56M -5.21M -4.75M -8.94M -612M -9.09M -61.04M -23.92M -306M -24.09M -23.57M |
| Net Debt | -4.79B -30.09M -26.08M -24.41M -22.28M -41.92M -2.87B -42.63M -286M -112M -1.44B -113M -111M | -3.9B -24.48M -21.22M -19.86M -18.12M -34.1M -2.33B -34.67M -233M -91.24M -1.17B -91.92M -89.92M |
Employees
51
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | ¥5,400.00 | +7.78% | 156,500 |
| 07/08/26 | ¥5,010.00 | +2.45% | 70,800 |
| 06/08/26 | ¥4,890.00 | -1.11% | 69,000 |
| 05/08/26 | ¥4,945.00 | +4.44% | 112,200 |
| 04/08/26 | ¥4,735.00 | +4.41% | 110,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4894 Stock
Select your edition
All financial news and data tailored to specific country editions
